Spruce Biosciences, Inc.
SPRB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$53,036 | -$47,919 | -$46,180 | -$42,292 |
| Dep. & Amort. | $46 | $70 | $429 | $68 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $4,622 | $0 | $3,958 |
| Change in WC | -$8,571 | $10,356 | $1,132 | $1,955 |
| Other Non-Cash | $5,597 | -$404 | $2,936 | $434 |
| Operating Cash Flow | -$55,964 | -$33,275 | -$41,683 | -$35,877 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$7 | -$8 | -$93 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$11,881 | -$36,800 | -$79,075 |
| Inv. Sales/Matur. | $0 | $67,665 | $60,500 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $55,777 | $23,692 | -$79,168 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,622 | -$1,622 | $0 | $220 |
| Stock Issued | $246 | $53,616 | -$201 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$246 | -$2,854 | -$40 | $423 |
| Financing Cash Flow | -$1,622 | $49,140 | -$241 | $643 |
| Forex Effect | $0 | $0 | $187 | $0 |
| Net Chg. in Cash | -$57,586 | $71,642 | -$18,045 | -$114,402 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $96,339 | $24,732 | $42,748 | $157,366 |
| End Cash | $38,753 | $96,374 | $24,703 | $42,964 |
| Free Cash Flow | -$55,964 | -$33,282 | -$41,691 | -$35,970 |